Review of the Centers for Disease Control and Prevention's smallpox vaccination program implementation. Letter report # 2 / Committee on Smallpox Vaccination Program Implementation, Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies.
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
- text
- computer
- online resource
- 058548953X
- 9780585489537
- Smallpox -- Vaccination
- Smallpox vaccine
- Emergency medical services -- United States
- Medical policy -- United States
- Public health -- United States
- Public health
- Smallpox -- prevention & control
- Bioterrorism -- prevention & control
- Smallpox Vaccine
- Public Health
- Program Evaluation
- United States
- Variole -- Vaccination
- Vaccin antivariolique
- Services des urgences médicales -- États-Unis
- Politique sanitaire -- États-Unis
- Santé publique -- États-Unis
- Santé publique
- public health
- MEDICAL -- Preventive Medicine
- MEDICAL -- Forensic Medicine
- MEDICAL -- Public Health
- Emergency medical services
- Medical policy
- Public health
- Smallpox -- Vaccination
- Smallpox vaccine
- United States
- 614.521 22
- RA644.S6 I57 2003eb
- WC 588
Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
![]() |
OPJGU Sonepat- Campus | E-Books EBSCO | Available |
Title from PDF title page.
Includes bibliographical references.
In this report, the committee addresses several important issues: the vaccination program's need for evaluation (including program safety) and clearly defined objectives; a needed emphasis on defining preparedness against smallpox attack; CDC's communications plans; CDC's training and education efforts; the systems for monitoring the safety of the vaccine; the need for a compensation program; and matters of resource allocation.
Support for this project was provided by Centers for Disease Control and Prevention. The views presented in this report are those of the Institute of Medicine Committee on Smallpox Vaccination Program Implementation and are not necessarily those of the funding agencies.
Version viewed November 14, 2014.
Current program context -- Summary of key messages -- Overarching issues: preparedness and evaluation -- Focus on preparedness -- Defining preparedness -- Concerns about program expansion and implication for preparedness -- Need for evaluation -- Programmatic issues -- Communication -- Overarching communication issues -- Communication specifics -- Communicating with the general public -- Communicating with the media -- Communicating with health care workers and others -- Training and education -- Broad issues relevant to training and education -- Specific issues in training and education -- Data to assess vaccine and program safety -- Pre-event vaccination system (PVS) -- Survey to assess common adverse reactions -- Active surveillance for serious adverse events and monitoring common adverse events -- Active surveillance for serious adverse events and monitoring common adverse events -- Active surveillance system -- Hospital smallpox vaccination monitoring system (HSVMS) -- Implications of program expansion for collection of data on adverse events -- ACIP working group on smallpox vaccine safety -- Reporting adverse events -- Compensation -- Worker's compensation -- Lack of compensation impeding program progress -- Notification about availability of compensation or lack of compensation -- Funding -- Additional data that should be gathered -- Concluding remarks.
Access restricted to subscribing institutions.
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide
There are no comments on this title.